7th American Drug Delivery & Formulation Summit

28 – 29 August 2017 | Boston

www.ddfsummit.com

 

Innovative solutions to the greatest challenges in pharmaceutical development

 

The growth of biopharma and patient compliance issues have encouraged us to adopt a drug delivery mind set from discovery through to production.

 

Every year we see innovation and breakthroughs at every level of drug development.

 

The DDF Summit brings the most innovative and exciting studies to you.

 

Covering both small molecules and biologics, you’ll find new technologies, concepts and case studies in areas such as…

 

  • Formulation design for poorly soluble compounds
  •  The potential of nanotechnology for better deliverability
  •  The latest controlled released technologies
  •  Improving patient compliance by harnessing data and the latest smart device technology
  • Optimising formulations for continuous manufacturing
  • Overcoming the blood brain barrier and challenges in oral delivery of biologics
  • Reformulation and biosimilars 

Download the brochure here.


9th Global Drug Delivery & Formulation Summit

12 – 14 March 2018 | Berlin

www.ddfevent.com

 

The 2017 summit was an intense and energetic exchange of ideas, experiences and business cards. Berlin hosted 75 speakers, 35 solution providers and 340 attendees across 3 days packed with content and networking.

 

If you’d like to see what it was all about then check out the post event report here.

 

The 2018 agenda is already well underway with the following speakers on the programme: 

  • Rene Van Nostrum, Associate Professor, Utrecht University
  • Prof. Dr. Sarah Hedtrich, Professor, Freie Universitat Berlin
  • Sabine Eichling, Senior Scientist II, AbbVie
  • Tarik Khan, Group Leader, Late-Stage Pharmaceutical and Processing Development, Roche
  •  Jeffrey Hemenway, Senior Research Scientist I, Formulation and Process Development, Gilead Sciences
  • Gregoire Schwach, Head of Drug Delivery, PTD Biologics Europe, Roche
  • Markus Krummer, Head of Continuous Manufacturing, Novartis
  • Sudhakar Garad, Global Head of Chemical and Pharmaceutical Profiling, NIBR
  •  Yash Kapoor, Associate Principal Scientist, MSD
  • Prof. Gerhard Winter, Chair of Pharmaceutical Technology and Biopharmaceutics, LMU Munich
  • Annette Bak, Senior Director, Head of Advanced Drug Delivery, AstraZeneca
  •  Juan Irache, Professor of Pharmaceutical Technology, University of Navarra
  • Kathrin Spielberger, Lab Head Formulation Development, Sanofi
  • Lorenz Meinel, Professor for Pharmaceutics and Biopharmacy, Wurzburg University

See the full list confirmed so far here.